Treatment of the heparin-induced thrombosis-thrombocytopenia syndrome by very low dose streptokinase.
Ferrari
E
E
Department of Cardiology, Hopital Pasteur, Nice, France.
Morand
P
P
Baudouy
M
M
D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects*; D004334:Drug Administration Schedule; D005260:Female; D006493:Heparin / Q000009:adverse effects*; D006801:Humans; D013300:Streptokinase / Q000008:administration & dosage* / Q000627:therapeutic use; D013577:Syndrome; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000188:drug therapy*; D015912:Thrombolytic Therapy; D013927:Thrombosis / Q000139:chemically induced* / Q000188:drug therapy*
D000925:Anticoagulants; D006493:Heparin; D013300:Streptokinase